Nimodipine: Recall – Crystallization of Fill Material

by FDA on September 5, 2012

in MedWatch

The product may no longer be bioequivalent and may potentially affect patients who are being treated for a medical emergency.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Leave a Comment

Previous post:

Next post: